01.01.04
Indication: Heart disease risk factors
Source: American Heart Association’s Scientific Sessions, November 2003
Research: A researcher from the University of Maryland enrolled 96 healthy adults with normal cardiovascular profiles in the study, randomly placed into four treatment groups. Three groups took a daily dose of 200 mg, 600 mg or 1000 mg of DHA (Neuromins®) while the fourth group took a placebo. Patients’ lipid levels were measured at the outset of the trial and again at two and four weeks of supplementation.
Results: Patients receiving DHA experienced a 5% dose-dependent increase in HDL cholesterol, with maximum effect occurring with 600 mg per day. DHA supplementation also resulted in a dose-dependent decrease in patients’ triglyceride levels, with a maximum 13% reduction occurring with 1000 mg per day. In addition, DHA supplementation had a beneficial impact on patients’ LDL cholesterol.
Source: American Heart Association’s Scientific Sessions, November 2003
Research: A researcher from the University of Maryland enrolled 96 healthy adults with normal cardiovascular profiles in the study, randomly placed into four treatment groups. Three groups took a daily dose of 200 mg, 600 mg or 1000 mg of DHA (Neuromins®) while the fourth group took a placebo. Patients’ lipid levels were measured at the outset of the trial and again at two and four weeks of supplementation.
Results: Patients receiving DHA experienced a 5% dose-dependent increase in HDL cholesterol, with maximum effect occurring with 600 mg per day. DHA supplementation also resulted in a dose-dependent decrease in patients’ triglyceride levels, with a maximum 13% reduction occurring with 1000 mg per day. In addition, DHA supplementation had a beneficial impact on patients’ LDL cholesterol.